In another of our exclusive recording from Cambridge Tech Week we hear from leading experts as they explore the frameworks, policies, and innovations shaping the ethical expansion of AI.

As leaders race to integrate AI, ensuring safety, ethics, and trust is more critical than ever. How can we scale AI responsibly while mitigating risks, avoiding bias, and maintaining transparency?

The expert panel includes Emilie van der Lande (Creative Intelligence), Daniel Quirke (Wayve), Dr Jakob Mokander (Tony Blair Institute) and Ray Eitel-Porter (Lumyz Advisory).

Key takeaways

- Cambridge is setting new benchmarks for innovation and investment in AI, biotech, and space tech.

- Scaling responsibly means embedding AI governance, risk assessment, and inclusion at every level.

- The debate on regulation favours targeted, industry-led frameworks

- Mobility and AI are merging - promise and complexity will require cooperation between startups, regulators, and the public.

- The tech community should focus on people, not just software: “Stop thinking about tech as tech; think about the human risks.”

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

This week on Cambridge Tech Podcast, we sit down with David Fyfe and Kamil Sokolowski from Kodiaq Technologies for a conversation that left us excited about the future of energy storage.

Key insights

Metal-Free, Organic Electrolytes: Kodiaq is developing next-gen organic electrolytes for flow batteries, avoiding the supply chain risks and costs tied to traditional metals like vanadium.

Enhanced Energy Density: They had already demonstrated that the energy their electrolyte could absorb was twice that of existing vanadium technology.

Drop-In Replacement: Their solution can potentially retrofit existing vanadium battery systems, instantly increasing capacity without a total system overhaul.

Resilience & Simplicity: Unlike current technologies that need strict air-free conditions, Kodiaq’s electrolyte is “oxygen-tolerant” -making construction, operation, and maintenance more flexible and less expensive.

Sustainability & Sovereignty: Kamil notes, "Developing this chemistry removes the dependence on the mining sector. These electrolytes can be produced anywhere and recycled for a second life."

Licensing-Led Approach: Inspired by models like ARM, Kodiaq plans to supply the chemistry and intellectual property, leaving battery manufacturing and integration to partners.

Global Impact, Local Roots: With worldwide ambitions, they’re actively building collaborations - especially seeking corporate partners ready to pilot their tech.

As renewables explode worldwide, storing energy safely, efficiently, and scalably is the central challenge of our net-zero future. Kodiaq could be the company to crack this problem - right from Cambridge’s legendary cluster.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

This week’s episode is a deep-dive interview with Finn Stevenson, cofounder and CEO of Flok Health, who brings a unique combination of medical expertise, startup experience, and relentless ambition to solve one of healthcare’s biggest headaches: scalable, accessible physiotherapy.

Key Takeaways:

Drawing on his experiences as an Olympic-level rower and healthtech professional, Finn noticed a gap: “For most people, access to high-quality, frequent physio is nearly impossible.” Enter Flok: an AI-powered physiotherapist offering on-demand, regulation-compliant digital care.

Rather than building another SaaS product, Flok became a licensed healthcare provider. “We are a CQC-approved provider, treating NHS patients directly using our technology and clinicians.” This makes procurement smoother and delivers real outcomes for both patients and the NHS.

Flok’s approach shuns off-the-shelf LLMs in favour of a domain-specific language for clinical reasoning, ensuring safe, explainable decision-making at every step. The system combines real-time video assembly (with a real physiotherapist, Kirsty, as the face of the AI) and robust guardrails against clinical risk.

The results speak for themselves: 68% of patients offered Flok’s service choose it over traditional care, covering ages 18 to 75, and less than 2% need traditional escalation. “Positive patient feedback is central. If people aren’t happy, we don’t have a business.”

Investment Ready: Raised £3.2M pre-product, pre-team. Investors love the addressable market: 80% of healthcare spend is on the delivery of services, not just tools.

Built in Cambridge: Access to deep tech talent, regulatory expertise, and Europe’s largest bio campus makes Cambridge a “no-brainer” HQ.

Actively Hiring: From engineering to clinical and commercial roles - Flok is scaling rapidly and innovating across new therapy areas.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.